dm+d
36621009
Articles
Choosing a medicine to delay periods
1 May 2024
Medroxyprogesterone acetate (SC-DMPA) injection for contraception
5 October 2021A PGD template developed by SPS and the Faculty of Sexual and Reproductive Health (FSRH).
Medroxyprogesterone acetate (DMPA) IM injection for contraception
5 October 2021A PGD template developed by SPS and the Faculty of Sexual and Reproductive Health (FSRH).
Medicine Compliance Aid Stability
PfizerPharmacia Ltd
Pharmacia Ltd
Pfizer
Tablets 2.5mg, 5mg, 10mg, 100mg, 200mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from light. Airtight container
22 November 2022
Lactation Safety Information
Oral for breast, endometrial or renal cell cancer
Oral
for breast, endometrial or renal cell cancer
No published evidence of safety of breastfeeding when used to treat maternal cancer
May interfere with early lactation
24 September 2020
For endometriosis
For endometriosis
No published evidence of safety of breastfeeding when used to treat endometriosis
Avoid until lactation well established
24 September 2020
For contraception
For contraception
Nonhormonal contraception or oral POC until 6 weeks postpartum
Moderate level of published evidence of use in breastfeeding
Small risk of interference with early lactation
24 September 2020